PTMA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.896000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.755200E-01
Normal-vs-Stage2
8.854400E-01
Normal-vs-Stage3
9.072000E-01
Normal-vs-Stage4
3.567800E-01
Stage1-vs-Stage2
4.550000E-01
Stage1-vs-Stage3
9.045000E-01
Stage1-vs-Stage4
2.796600E-01
Stage2-vs-Stage3
6.956000E-01
Stage2-vs-Stage4
2.330000E-01
Stage3-vs-Stage4
4.412200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.806800E-01
Normal-vs-AfricanAmerican
2.111800E-01
Normal-vs-Asian
6.890800E-01
Caucasian-vs-AfricanAmerican
3.172000E-01
Caucasian-vs-Asian
4.910600E-01
AfricanAmerican-vs-Asian
1.447420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.557800E-01
Normal-vs-Female
9.753000E-01
Male-vs-Female
7.417200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.495000E-01
Normal-vs-Age(41-60Yrs)
7.335200E-01
Normal-vs-Age(61-80Yrs)
8.683000E-01
Normal-vs-Age(81-100Yrs)
6.312200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.332590E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.635600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.311700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.900100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.457400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.792620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.456800E-01
Normal-vs-Daily Drinker
8.849200E-01
Normal-vs-Weekly Drinker
9.424600E-01
Normal-vs-Occasional Drinker
7.859000E-01
Normal-vs-Social Drinker
4.595800E-01
Non Drinker-vs-Daily Drinker
8.898000E-01
Non Drinker-vs-Weekly Drinker
8.112000E-01
Non Drinker-vs-Occasional Drinker
7.568600E-01
Non Drinker-vs-Social Drinker
2.202200E-01
Daily Drinker-vs-Weekly Drinker
7.046400E-01
Daily Drinker-vs-Occasional Drinker
8.590000E-01
Daily Drinker-vs-Social Drinker
2.175000E-01
Weekly Drinker-vs-Occasional Drinker
5.601600E-01
Weekly Drinker-vs-Social Drinker
3.658400E-01
Occasional Drinker-vs-Social Drinker
1.239020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.792200E-01
Normal-vs-Grade 2
6.055400E-03
Normal-vs-Grade 3
2.571700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.961900E-04
Grade 1-vs-Grade 3
1.095860E-03
Grade 1-vs-Grade 4
2.792200E-01
Grade 2-vs-Grade 3
8.811800E-01
Grade 2-vs-Grade 4
6.055400E-03
Grade 3-vs-Grade 4
2.571700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.709800E-01
Normal-vs-NonDiabetic
9.626600E-01
Diabetic-vs-NonDiabetic
7.956600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.145800E-01
Normal-vs-NoPancreatitis
9.744400E-01
Pancreatitis-vs-NoPancreatitis
5.950400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.516400E-01
Normal-vs-N1
9.027800E-01
N0-vs-N1
5.299200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.776400E-01
Normal-vs-TP53-NonMutant
1.855710E-02
TP53-Mutant-vs-TP53-NonMutant
5.04449815252883E-11
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
